News
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
In March, a German court sided with American pharmaceutical firm Moderna in its claim that BioNTech and Pfizer had broken one of its patents in making its Covid-19 vaccine. Provided by SyndiGate Media ...
Apple and Trump detail $100 billion U.S. spending expansion: Here's what to know Brandon Blackstock, Kelly Clarkson's ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac US$740 ...
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
When COVID-19 cases were surging, Dr. David Wohl saw patients “hungry for air” fill UNC hospital wards. What most saved lives ...
News of a trade secrets leak involving TSMC and an action in Japan against AI startup Perplexity were also among the top ...
In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...
A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department ...
This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...
Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results